MediFind found 63 doctor with experience in Relapsed Refractory Multiple Myeloma (RRMM) near Santa Monica, CA. Of these, 55 are Experienced, 6 are Advanced, 1 are Distinguished and 1 are Elite.
The Regents Of The University Of California
Gary Schiller is a Hematologist Oncology specialist and a Hematologist in Los Angeles, California. Dr. Schiller is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
The Regents Of The University Of California
Sarah Larson is a Hematologist Oncology specialist and a Hematologist in Los Angeles, California. Dr. Larson is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.
The Regents Of The University Of California
Robert Kang is an Otolaryngologist and a General Surgeon in Los Angeles, California. Dr. Kang is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Melanoma, Salivary Gland Tumors, Acinic Cell Carcinoma of Salivary Glands, Gastrostomy, and Bone Marrow Aspiration.
The Regents Of The University Of California
Patricia Young is an Oncologist in Los Angeles, California. Dr. Young has been practicing medicine for over 16 years and is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), and Bone Marrow Aspiration.
The Regents Of The University Of California
Sven De Vos is a Hematologist Oncology specialist and a Hematologist in Los Angeles, California. Dr. De Vos is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
Michael Rosove is a Hematologist and an Oncologist in Los Angeles, California. Dr. Rosove is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Polycythemia Vera, Chronic Lymphocytic Leukemia (CLL), Essential Thrombocythemia, and Richter Syndrome.
The Regents Of The University Of California
Christopher Seet is a Hematologist and an Oncologist in Los Angeles, California. Dr. Seet is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Aspiration, and Bone Marrow Transplant.
Brian Laing is a primary care provider, practicing in Family Medicine in Santa Monica, California. Dr. Laing is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Relapsed Refractory Multiple Myeloma (RRMM), and Chronic Pain.
The Regents Of The University Of California
Zorawar Noor is a Hematologist and an Oncologist in Santa Monica, California. Dr. Noor is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Pancreatic Cancer, and Familial Pancreatic Cancer.
The Regents Of The University Of California
Molly Oswald is a Nurse Practitioner in Santa Monica, California. Ms. Oswald is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM) and Smoldering Multiple Myeloma.
The Regents Of The University Of California
Daniel Greenwald is an Oncologist and a Hematologist in Santa Monica, California. Dr. Greenwald is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Severe Congenital Neutropenia, Chronic Familial Neutropenia, Familial Colorectal Cancer, and Large-Cell Immunoblastic Lymphoma.
The Regents Of The University Of California
Solomon Hamburg is a Hematologist Oncology specialist and a Hematologist in Santa Monica, California. Dr. Hamburg is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Hodgkin Lymphoma, Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia (CLL), and Severe Congenital Neutropenia.
The Regents Of The University Of California
Mary Sehl is a Hematologist and an Oncologist in Santa Monica, California. Dr. Sehl is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration.
The Regents Of The University Of California
Diane Prager is a Hematologist Oncology specialist and an Oncologist in Santa Monica, California. Dr. Prager has been practicing medicine for over 43 years and is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Severe Congenital Neutropenia, Angiosarcoma, and Bone Marrow Aspiration.
Cedars-Sinai Medical Care Foundation
Azarmindokht Khosravi is an Endocrinologist in Los Angeles, California. Dr. Khosravi is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Melorheostosis with Osteopoikilosis, Melorheostosis, Osteopenia, and Osteoporosis.
The Regents Of The University Of California
Wanxing Chai is a Hematologist and an Oncologist in Los Angeles, California. Dr. Chai is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.
The Regents Of The University Of California
Caspian Oliai is a Hematologist and an Oncologist in Los Angeles, California. Dr. Oliai is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
The Regents Of The University Of California
Eri Hirofuji is a Nurse Practitioner in Los Angeles, California. Ms. Hirofuji is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Chronic Graft Versus Host Disease (cGvHD), and Classical Hodgkin Lymphoma.
Phillip Beron is a Radiation Oncologist in Los Angeles, California. Dr. Beron is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Squamous Cell Skin Carcinoma, Breast Cancer, Angiosarcoma, and Breast Cancer in Men.
The Regents Of The University Of California
Tasha Lin is a Hematologist Oncology specialist and a Hematologist in Los Angeles, California. Dr. Lin is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Multiple Myeloma, Acute Lymphoblastic Leukemia (ALL), Smoldering Multiple Myeloma, and Diffuse Large B-Cell Lymphoma (DLBCL).
Last Updated: 10/30/2025